LifeWorks Mental Health Index™ finds 34 per cent of Canadians indicate their workplace does not provide training, coaching or support to deal with conflict or aggression TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its monthly Mental Health Index™ that showed the 20 per cent of Canadians that have … [Read more…]
LUXEMBOURG–(BUSINESS WIRE)–Gold Standard Diagnostics Europe continues its response to the threat of emerging infectious diseases by developing a new multiplex Real-time PCR assay for the detection of the monkeypox virus and its differentiation from other orthopox viruses. The monkeypox virus has raised significant concerns given its recent spread, with more than 2500 confirmed cases in … [Read more…]
MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its investor relation team will participate in the following upcoming investor conference: Conference Portzamparc – Evenement Corporate Access, Paris (in-person event) Event Date: June 30, 2022 About Innate Pharma: Innate Pharma S.A. is a global, clinical-stage … [Read more…]
POTOMAC, Md.–(BUSINESS WIRE)–#IGC–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces its financial results for Fiscal Year Ended March 31, 2022. Highlights for Fiscal 2022: IGC completed the first-in-human safety and tolerability trial on its tetrahydrocannabinol (THC) based investigational new drug IGC-AD1. During the trial, the Company discovered positive signals for improving … [Read more…]
SHANGHAI–(BUSINESS WIRE)–The fifth China International Import Expo will take place from November 5-10 this year. Buoyed by its opening-up policy, continuous optimization of the business environment and strong economic resilience, China will remain a hot investment destination in the years to come, said global experts at the World Economic Forum (WEF) 2022 in Davos, Switzerland. … [Read more…]
VAXNEUVANCE is the first new pneumococcal conjugate vaccine for pediatric populations to be recommended in almost a decade RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) unanimously voted to include … [Read more…]
LOS ANGELES & SALT LAKE CITY–(BUSINESS WIRE)–Reviv3 Procare Company (OTCQB:RVIV) today announced that it has successfully completed the previously announced acquisition of substantially all assets of AXIL & Associated Brands, a leading provider of hearing protection and enhancement products. “This transaction expands our product portfolio across a much wider range of industries and significantly broadens … [Read more…]
NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: FOUR YOUNG CHILDREN RECEIVE COVID-19 VACCINE AT COHEN CHILDREN’S Americans have another tool in the fight against coronavirus disease 2019 (COVID-19) after the U.S. Food and Drug Administration granted emergency use authorization for Pfizer-BioNTech’s … [Read more…]
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today released its 2021 Corporate Sustainability / ESG Report entitled Better Takes Shape. Aptar’s 2021 Corporate Sustainability / ESG Report highlights activities across the Company’s global operations and summarizes milestones measured and … [Read more…]
In this Retrospective Matched Case Control Study, Belzupacap Sarotalocan Achieved Statistically Significant Vision Preservation Compared to Plaque Radiotherapy, the Current Standard of Care CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, reported results from a retrospective, matched case … [Read more…]
